GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MEDIVATION INC (MDVN) [hlAlert]

Rating:
Buy MDVN
up 983.17 %

MEDIVATION INC (MDVN) rated Buy with price target $63 by Summer Street Research

Posted on: Monday,  Jan 23, 2012  9:25 AM ET by Summer Street Research

Summer Street Research rated Buy MEDIVATION INC (NASDAQ: MDVN) on 01/23/2012. Previously Summer Street Research rated Buy MEDIVATION INC (NASDAQ: MDVN) on
10/18/2011., when the stock price was $8.50. Since then, MEDIVATION INC has gained 983.18% as of 01/27/2016's recent price of $92.07.
If you would have followed the previous Summer Street Research's recommendation on MDVN, you would have gained 983.17% of your investment in 1562 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

Summer Street Research s is an institutional equity research and trading firm that focuses exclusively on the healthcare sector. Our mission is to help our clients maximize returns by providing the best healthcare research, ideas, and investment opportunities. In recognition of our excellence in research, Summer Street Research Partners was the 2005 winner of Institutional Investor's "Best Independents" award for both biotechnology and specialty pharmaceutical research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/23/2012 9:25 AM Buy
None
25.59 31.50
as of 12/31/2012
1 Week up  2.25 %
1 Month down  -1.89 %
3 Months down  -9.21 %
1 YTD up  121.90 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/18/2011 9:25 AM Buy
None
8.50 13.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy